Joseph Glass, PhD, MSW, is a senior investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI). Before joining KPWHRI in July 2016, he was an assistant professor at the University of Wisconsin – Madison School of Social Work.
Dr. Glass’s research seeks to identify how effective health care interventions for unhealthy alcohol and drug use can reach more people. Much of his work aims to develop, test, and implement modern models of care that proactively deliver evidence-based treatments within health care settings and that provide support to patients while they seek substance use treatment.
Dr. Glass’s work is informed by his practical experience in the field. After receiving a Master of Social Work from the University of Michigan, Dr. Glass was a psychiatric social worker at the Veterans Affairs Ann Arbor Healthcare System. There he developed expertise in social work case management and evidence-based treatments for anxiety, depression, and substance use disorders.
He completed a 5-year career development award funded by the National Institute on Alcohol Abuse and Alcoholism in 2021, which allowed him to obtain intensive training in clinical trials and implementation science. Currently, he has 2 active randomized controlled trials.
Dr. Glass also co-leads a 2-year study funded by the National Institute on Alcohol Abuse and Alcoholism to validate and improve approaches for monitoring the quality of care for alcohol use disorder. He also enjoys serving as a co-investigator and consultant, providing expertise and support to studies led by his colleagues.
Dr. Glass is an affiliate associate professor of health systems and population health, and of psychiatry and behavioral sciences, at the University of Washington.
Unhealthy alcohol and drug use
Access and treatment-seeking patterns
Smartphone and web-based interventions in health care
Prevention and treatment
The SPARC trial successfully implemented behavioral health care into primary care. On our website, you can access tools for behavioral health integration, as well as frequently asked questions and publications.
Yeung K, Richards J, Goemer E, Lozano P, Lapham G, Williams E, Glass J, Lee A, Achtmeyer C, Caldeiro R, Parrish R, Bradley K. Costs of using evidence-based implementation strategies for behavioral health integration in a large primary care system. Health Serv Res. 2020 Dec;55(6):913-923. doi: 10.1111/1475-6773.13592. PubMed
Frost MC, Blosnich JR, Lehavot K, Chen JA, Rubinsky AD, Glass JE, Williams EC. Disparities in documented drug use disorders between transgender and cisgender U.S. Veterans Health Administration patients. J Addict Med. 2021 Jul-Aug 01;15(4):334-340. doi: 10.1097/ADM.0000000000000769. PubMed
Friedmann PD, Abraham A, Evans E, Glass J, Ilgen M, Montgomery L. Editorial: COVID-19 and its impact on SUD treatment. J Subst Abuse Treat. 2020 Oct;117:108091. doi: 10.1016/j.jsat.2020.108091. PubMed
Oh H, Nicholson HL Jr, Koyanagi A, Jacob L, Glass J. Urban upbringing and psychiatric disorders in the United States: a racial comparison. Int J Soc Psychiatry. 2021 Jun;67(4):307-314. doi: 10.1177/0020764020950781. Epub 2020 Aug 21. PubMed
Glass JE, Williams EC, Oh H. Racial/ethnic discrimination and alcohol use disorder severity among United States adults. Drug Alcohol Depend. 2020 Aug 10;216:108203. doi: 10.1016/j.drugalcdep.2020.108203. PubMed
Clarissa Hsu and Jess Mogk share a new way to fast-track insights from qualitative data.
Joe Glass explores how to engage patients with treatment for alcohol or drug use.
A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.
A new primary care approach improves alcohol-related preventive care as well as care for alcohol use disorder.